25(S)-27-hydroxy Cholesterol (Synonyms: (25S)-26-hydroxy cholesterol) |
| Katalog-Nr.GC11700 |
liver x receptors (LXRα and LXRβ) activator
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 56845-83-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
25(S)-27 hydroxy Cholesterol is a stereoisomer of the endogenous oxysterol 27-hydroxy cholesterol. 27-hydroxy Cholesterol is a sterol 27-hydroxylase-mediated cholesterol hydroxylation product involved in activating LXRα and LXRβ and potently suppressing cholesterol biosynthesis [1,2].
Liver X receptors (LXRs) belong to the nuclear receptor superfamily member. LXRs are ligand-activated transcription factors containing two LXR isoforms termed as α and β. LXRs play central roles in the transcriptional control of lipid metabolism. LXRs function as nuclear cholesterol sensors that are activated in response to elevated intracellular cholesterol levels in multiple cell types. Activation of LXRs induces the expression of the genes involved in cholesterol absorption, transport, efflux, and excretion. LXRs are potential targets for a variety of diseases, such as hypertriglyceridemia [3]. LXRs have also been involved in modulating immune and inflammatory responses in macrophages [3].
25(S)-27 hydroxy Cholesterol was the less predominant-occurring (~20%) stereoisomer of the endogenous oxysterol 27-hydroxy cholesterol. 27-hydroxy Cholesterol activated LXRα and LXRβ with the EC50 values of 85 and 71 nM, respectively [1,2].
References:
[1] Fu, X. ,Menke, J.G.,Chen, Y., et al. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. The Journal of Biological Chemisty 276(42), 38378-38387 (2001).
[2] Javitt, N. B. 25R,26-Hydroxycholesterol revisited: Synthesis, metabolism, and biologic roles. Journal of Lipid Research 43, 665-670 (2002).
[3] Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling[J]. The Journal of clinical investigation, 2006, 116(3): 607-614.
| Cas No. | 56845-83-1 | SDF | |
| Überlieferungen | (25S)-26-hydroxy cholesterol | ||
| Chemical Name | (25S)-cholest-5-ene-3β,26-diol | ||
| Canonical SMILES | O[C@@H]1CC2=CC[C@]3([H])[C@@](CC[C@]4([C@@]3([H])CC[C@]4([H])[C@@H](CCC[C@H](C)CO)C)C)([H])[C@](C)2CC1 | ||
| Formula | C27H46O2 | M.Wt | 402.7 |
| Löslichkeit | ≤20mg/ml in ethanol;0.1mg/ml in DMSO;2mg/ml in dimethyl formamide | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.4832 mL | 12.4162 mL | 24.8324 mL |
| 5 mM | 0.4966 mL | 2.4832 mL | 4.9665 mL |
| 10 mM | 0.2483 mL | 1.2416 mL | 2.4832 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *